Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks

Birring, S. S., Dicpinigaitis, P. V., Smith, J. A., Morice, A. H., McGarvey, L. P., Pavord, I. D., … Rosa, C. L. (2023, June 1). Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks. American Journal of Respiratory and Critical Care Medicine. American Thoracic Society. https://doi.org/10.1164/rccm.202211-2128LE